Results 11 to 20 of about 1,543,151 (246)

Treatment of colorectal liver metastases [PDF]

open access: yesWorld Journal of Surgical Oncology, 2011
Le cancer colorectal (CCR) est le troisième cancer le plus fréquent dans le monde. Les métastases hépatiques sont le site le plus fréquent de métastases colorectales. Le pronostic des métastases hépatiques colorectales résécables (CRLM) a été amélioré ces dernières années avec la prise en compte de la chimiothérapie et de la résection chirurgicale dans
Nabil Ismaili, Ismaili Nabil
openaire   +5 more sources

MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma. [PDF]

open access: yesPLoS ONE, 2016
OBJECTIVE:Metastasis is the major cause of death in colorectal cancer patients. Expression of certain miRNAs in the primary tumors has been shown to be associated with progression of colorectal cancer and the initiation of metastasis.
Fabian Feiersinger   +10 more
doaj   +4 more sources

United Kingdom criteria for liver transplantation in the setting of isolated unresectable colorectal liver metastases [PDF]

open access: yes, 2023
Aim Studies have demonstrated that liver transplantation may be an effective treatment for isolated unresectable colorectal cancer liver metastases (CRCLM). Published data suggest that 5-year survival may be as high as 80%; however, recurrent disease is
Prasad, R   +3 more
core   +1 more source

Immune mediated and direct killing of colorectal cancer by reovirus [PDF]

open access: yes, 2012
Colorectal cancer remains the second most prevalent cancer in the world. Novel treatment strategies are necessary, especially for the treatment of metastatic disease.
Adair, Robert Allan
core   +5 more sources

The predictive value of liver tests for the presence of liver metastases

open access: yesHepatic Oncology, 2023
Aim: To analyze the predictive value of biochemical liver tests in patients with malignant melanoma, breast, colorectal or lung cancers at the time of diagnosis of liver metastases.
Alexandra V Kimchy   +5 more
doaj   +1 more source

Two cases of colorectal liver metastasis with residual liver recurrence after a long recurrence-free survival period

open access: yesSurgical Case Reports, 2023
Background The rate of residual liver recurrence after the resection of colorectal liver metastases is high, and most cases recur within 5 years of the initial hepatectomy. Here, we report two cases of residual liver recurrence after radical resection of
Shotaro Yagi   +11 more
doaj   +1 more source

Liver resection for colorectal metastases [PDF]

open access: yesAnnals of The Royal College of Surgeons of England, 2004
BACKGROUND: Colorectal cancer is the second commonest malignancy in the UK. Metastases to the liver occur in greater than 50% of patients and remain the biggest determinant of outcome in these patients. Liver resection is a safe procedure that achieves good long-term survival, but surgery has traditionally been limited to select groups of patients. The
Robert, Church   +4 more
openaire   +2 more sources

Identificació de nous marcadors moleculars en metàstasi hepàtica de càncer colorectal [PDF]

open access: yes, 2010
[cat] L’objectiu d’aquest treball és la identificació i caracterització de les principals alteracions en metàstasi hepàtica (MH) de càncer colorectal (CCR) tant a nivell d’expressió gènica com de metilació de l’ADN.
Padullés Mosella, Laura
core   +6 more sources

Surgical treatment of colorectal cancer liver metastases

open access: yesActa Medica Lituanica, 2011
Background. Colorectal cancer is a major health problem. Approximately 25% of the patients present with liver metastases at initial diagnosis and more than 50% develop metastases in the course of illness.
Dainius ŠIMČIKAS   +4 more
doaj   +1 more source

Current trends and outcomes of surgical treatment of colorectal cancer with liver metastasis

open access: yesСибирский онкологический журнал, 2022
Aim. To analyze multimodal treatment outcomes in patients with liver metastases from colorectal cancer, who were treated at multidisciplinary cancer clinic. Material and methods.
A. V. Shabunin   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy